Leustatin
Links shared publicly online about this topic
Medical News: AAN: Cancer Drug Shows Promise as Oral MS Therapy - in Meeting Coverage, AAN from MedPage Today
medpagetoday.com — “SEATTLE -- Oral cladribine (Leustatin) significantly reduced relapse rates and disability progression in relapsing-remitting multiple sclerosis, it was reported here.” View full resource at medpagetoday.com
Most Recently Shared on April 30, 2009 at 5:01 pm By:
AAN: Cancer Drug Shows Promise as Oral MS Therapy http://medpagetoday.com/13996
Medical News: CMSC-ACTRIMS: Cancer Drug Shuts Down MS Activity - in Meeting Coverage, CMSC-ACTRIMS from MedPage Today
medpagetoday.com — “SAN ANTONIO -- Cladribine, an oral drug already marketed for hematologic cancers under the trade name Leustatin, was superior to placebo in reducing progression and other signs of MS disease activity,” View full resource at medpagetoday.com
Most Recently Shared on June 8, 2010 at 5:51 pm By:
CMSC-ACTRIMS: Cancer Drug Shuts Down MS Activity (CME/CE) http://bit.ly/bOkY8m
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MedPage Today
Daily, peer reviewed medical news for clinicians
-
FightCancer
Cancer news feed, formerly part of a blog. RSS suggestions welcome.
Advertisement
